Quintiles Phase One Clinical Trials India Private Limited

Conducts phase one clinical trials for pharmaceutical companies in India.

2009 | Hyderabad, Telangana (India) | Inactive
Last Updated:

Quintiles Phase One Clinical Trials India Profile

Key Indicators

  • Authorised Capital ₹ 38.00 Cr
  • Paid Up Capital ₹ 36.57 Cr
  • Company Age 15 Year, 8 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth -95.71%
  • Profit Growth -170.66%
  • Ebitda -266.59%
  • Net Worth -51.44%
  • Total Assets -1.51%

About Quintiles Phase One Clinical Trials India

Quintiles Phase One Clinical Trials India Private Limited (QPOCTIPL) is Dissolved (Liquidated) company established on 03 Jul 2009 with its office registered at Hyderabad, Telangana, India and has been running since 15 Year, 8 Months with a paid up capital of 36.57 Cr. According to MCA records, 3 Directors and 1 Signatories are linked to this company as of 16 Jan 2025.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U73100TG2009FTC064239

  • Company No.

    064239

  • Company Classification

    Private Limited Foreign Company Incorporated In India

  • Incorporation Date

    03 Jul 2009

  • Date of AGM

    29 Jun 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Healthcare

Who are the key members and board of directors at Quintiles Phase One Clinical Trials India?

Executive Team (1)

NameDesignationAppointment DateStatus
Khusboo Singhvi Company Secretary24-Apr-2019Current

Board Members (3)

NameDesignationAppointment DateStatus
Nilanjan Sinha Country flag representing In Director 14-Nov-2016Current
Arjun Aiyar Country flag representing In Director 01-Nov-2016Current
Haripprasad Kovalamuri Country flag representing In Director 15-May-2013Current

Financial Performance of Quintiles Phase One Clinical Trials India.

Quintiles Phase One Clinical Trials India Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 95.71% decrease. The company also saw a substantial fall in profitability, with a 170.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 51.44%.

Quintiles Phase One Clinical Trials India revenue growth over time
Quintiles Phase One Clinical Trials India profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-95.71%
Revenue from Operations
Total Assets
-1.51%
Profit or Loss
-170.66%
Net Worth
-51.44%
EBITDA
-266.59%

What is the Ownership and Shareholding Structure of Quintiles Phase One Clinical Trials India?

In 2017, Quintiles Phase One Clinical Trials India had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Quintiles Phase One Clinical Trials India?

Unlock and access historical data on people associated with Quintiles Phase One Clinical Trials India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Quintiles Phase One Clinical Trials India Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Quintiles Phase One Clinical Trials India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quintiles Phase One Clinical Trials India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Quintiles Phase One Clinical Trials India

Recent activity within the organization

  • Annual General Meeting

    Quintiles Phase One Clinical Trials India Private Limited last Annual general meeting of members was held on 29 Jun 2020 as per latest MCA records.

  • Balance Sheet

    Quintiles Phase One Clinical Trials India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.

  • Director Appointment

    Khusboo Singhvi was appointed as a Company Secretary was appointed as a Company Secretary on 24 Apr 2019 & has been associated with this company since 5 years 10 months .

  • Director Appointment

    Nilanjan Sinha was appointed as a Director was appointed as a Director on 14 Nov 2016 & has been associated with this company since 8 years 3 months .

  • Director Appointment

    Arjun Aiyar was appointed as a Director was appointed as a Director on 01 Nov 2016 & has been associated with this company since 8 years 4 months .

  • Director Appointment

    Haripprasad Kovalamuri was appointed as a Director was appointed as a Director on 15 May 2013 & has been associated with this company since 11 years 9 months .

Frequently asked questions

  • What is the Incorporation or founding date of Quintiles Phase One Clinical Trials India Private Limited?

    Quintiles Phase One Clinical Trials India Private Limited was incorporated on 03 Jul 2009.

  • What is authorized share capital and paid-up capital of Quintiles Phase One Clinical Trials India Private Limited?

    The authorized share capital of Quintiles Phase One Clinical Trials India Private Limited is ₹ 38.00 Cr and paid-up capital is ₹ 36.57 Cr.

  • Who are the current board members & directors of Quintiles Phase One Clinical Trials India Private Limited?

    Currently 4 directors are associated with Quintiles Phase One Clinical Trials India Private Limited.

    • Haripprasad Kovalamuri
    • Arjun Aiyar
    • Nilanjan Sinha
    • Khusboo Singhvi

  • What is the registered address of Quintiles Phase One Clinical Trials India Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Quintiles Phase One Clinical Trials India Private Limited is 7Th 8Th Floor Apollo Health Street Building City Behind Kbr Park, Jub Ilee Hills India, Hyderabad, Telangana, 500033.

  • What is the corporate identification number (CIN) and company number of Quintiles Phase One Clinical Trials India Private Limited?

    The corporate identification number (CIN) of Quintiles Phase One Clinical Trials India Private Limited is U73100TG2009FTC064239 and the company number is 064239 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Quintiles Phase One Clinical Trials India Private Limited?

    The Official website of Quintiles Phase One Clinical Trials India Private Limited is https://www.quintiles.com

  • What has been the recent revenue trend for Quintiles Phase One Clinical Trials India Private Limited?

    According to the financial reports for the fiscal year 2016, the revenue trend for Quintiles Phase One Clinical Trials India Private Limited has fallen by -95.71%.

  • What change has been observed in the net worth of Quintiles Phase One Clinical Trials India Private Limited, and by what percentage?

    The financial reports for the fiscal year 2016 indicates that The net worth of Quintiles Phase One Clinical Trials India Private Limited has experienced an downturn of -51.44%.

  • When was the last Balance Sheet of Quintiles Phase One Clinical Trials India Private Limited filed with the ROC?

    The most recent Balance Sheet for Quintiles Phase One Clinical Trials India Private Limited was filed with the ROC on 31 Mar 2020.

People also Viewed

Similar Companies Based on Preventive Health Services